2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast CancerHER2-positive Advanced Breast CancerRecruitingPhase 32026-06-03NCT07047365
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.Advanced Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingPhase 32026-01-22NCT07284134